Collegium Pharmaceutical, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for the quarter ending 2019-12-31 was 0.00 shares.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for the quarter ending 2019-09-30 was 0.00 shares.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for the quarter ending 2018-12-31 was -3.13M shares, a 258.05% decline year-over-year.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for the quarter ending 2018-09-30 was 0.00 shares.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for fiscal 2019 was 0.00 shares.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for fiscal 2018 was 0.00 shares, a 100.00% decline from fiscal 2017.
- Collegium Pharmaceutical, Inc. stock issued during period, shares, new issues for fiscal 2017 was 3.13M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 0.00 shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | |
| 2018-12-31 | -3.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 0.00 shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 5.11M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | |
| 2018-03-31 | 3.13M shares 10-Q · filed 2018-05-09 | |
| 2017-12-31 | 1.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 3.13M shares 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |